{"transactions":[{"id":4640544,"issuer":{"id":7692,"kind":"organization","name":"Akari Therapeutics Plc","symbol":"AKTX"},"owners":[{"id":184442,"kind":"person","name":"Vat-Ho Vatnak","position":1,"cik":"0002160022","reported_name":"Vat-Ho Vatnak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-14T21:21:58.000Z","date":"2026-10-12","kind":"grant","planned":false,"acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 5, 2026 (the \"Grant Date\"), the reporting person was granted an option to purchase 87,000 ADSs. This option grant is subject to forfeiture and cancellation if shareholder approval of a proposed amendment to the Issuer's equity incentive plan to increase the number of shares reserved for issuance under the plan is not obtained. The option will vest with respect to 25% on the 12-month anniversary of the Grant Date, with the remainder vesting in equal monthly installments over the next 36 months until fully vested on the 4-year anniversary of the Grant Date, subject to the grantee's continued service with the Company."}],"balance_after":87000,"derivative":{"exercise_price":8.94,"expiration_date":"2036-10-05","underlying":"American Depositary Shares representing Ordinary Shares","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001493152-26-047058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2160022/000149315226047058/ownership.xml","form_type":"4"}}]}